These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 32587680)

  • 1. An overview of prevalence, determinants and health outcomes of polypharmacy.
    Khezrian M; McNeil CJ; Murray AD; Myint PK
    Ther Adv Drug Saf; 2020; 11():2042098620933741. PubMed ID: 32587680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences.
    Pazan F; Wehling M
    Eur Geriatr Med; 2021 Jun; 12(3):443-452. PubMed ID: 33694123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on the clinical consequences of polypharmacy in older adults: a narrative review.
    Wastesson JW; Morin L; Tan ECK; Johnell K
    Expert Opin Drug Saf; 2018 Dec; 17(12):1185-1196. PubMed ID: 30540223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypharmacy in multimorbid older adults: protocol for a systematic review.
    Sirois C; Laroche ML; Guénette L; Kröger E; Cooper D; Émond V
    Syst Rev; 2017 May; 6(1):104. PubMed ID: 28526062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The patterns and implications of potentially suboptimal medicine regimens among older adults: a narrative review.
    Lee GB; Etherton-Beer C; Hosking SM; Pasco JA; Page AT
    Ther Adv Drug Saf; 2022; 13():20420986221100117. PubMed ID: 35814333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial.
    Sönnichsen A; Trampisch US; Rieckert A; Piccoliori G; Vögele A; Flamm M; Johansson T; Esmail A; Reeves D; Löffler C; Höck J; Klaassen-Mielke R; Trampisch HJ; Kunnamo I
    Trials; 2016 Jan; 17():57. PubMed ID: 26822311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A set of systematic reviews to help reduce inappropriate prescribing to older people: study protocol.
    Martinez YV; Renom-Guiteras A; Reeves D; Erandie Ediriweera de Silva R; Esmail A; Kunnamo I; Rieckert A; Sommerauer C; Sönnichsen A
    BMC Geriatr; 2017 Oct; 17(Suppl 1):231. PubMed ID: 29047332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot.
    McCarthy C; Clyne B; Corrigan D; Boland F; Wallace E; Moriarty F; Fahey T; Hughes C; Gillespie P; Smith SM
    Implement Sci; 2017 Aug; 12(1):99. PubMed ID: 28764753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action.
    Mangin D; Bahat G; Golomb BA; Mallery LH; Moorhouse P; Onder G; Petrovic M; Garfinkel D
    Drugs Aging; 2018 Jul; 35(7):575-587. PubMed ID: 30006810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes associated with prescribed medications in older adults with multimorbidity: protocol for a scoping review.
    Watt J; Tricco AC; Vyas M; Kohli K; Soin S; Abaeian M; Watt S; Straus SE
    BMJ Open; 2017 Feb; 7(2):e014529. PubMed ID: 28235972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimorbidity patterns in chronic older patients, potentially inappropriate prescribing and adverse drug reactions: protocol of the multicentre prospective cohort study MoPIM.
    Baré M; Herranz S; Jordana R; Gorgas MQ; Ortonobes S; Sevilla D; De Jaime E; Ibarra O; Martín C;
    BMJ Open; 2020 Jan; 10(1):e033322. PubMed ID: 31988230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of multimorbidity and polypharmacy among adults and older adults: a systematic review.
    Nicholson K; Liu W; Fitzpatrick D; Hardacre KA; Roberts S; Salerno J; Stranges S; Fortin M; Mangin D
    Lancet Healthy Longev; 2024 Apr; 5(4):e287-e296. PubMed ID: 38452787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is polypharmacy? A systematic review of definitions.
    Masnoon N; Shakib S; Kalisch-Ellett L; Caughey GE
    BMC Geriatr; 2017 Oct; 17(1):230. PubMed ID: 29017448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Overview of Systematic Reviews and Meta-Analyses on the Effect of Medication Interventions Targeting Polypharmacy for Frail Older Adults.
    Verma A; Saha S; Jarl J; Conlon E; McGuinness B; Trépel D
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication use in older patients and age-blind approach: narrative literature review (insufficient evidence on the efficacy and safety of drugs in older age, frequent use of PIMs and polypharmacy, and underuse of highly beneficial nonpharmacological strategies).
    Fialová D; Laffon B; Marinković V; Tasić L; Doro P; Sόos G; Mota J; Dogan S; Brkić J; Teixeira JP; Valdiglesias V; Costa S;
    Eur J Clin Pharmacol; 2019 Apr; 75(4):451-466. PubMed ID: 30610276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypharmacy and falls in the elderly: a literature review.
    Hammond T; Wilson A
    Nurs Midwifery Stud; 2013 Jun; 2(2):171-5. PubMed ID: 25414854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: A cross-sectional study.
    Lopez-Rodriguez JA; Rogero-Blanco E; Aza-Pascual-Salcedo M; Lopez-Verde F; Pico-Soler V; Leiva-Fernandez F; Prados-Torres JD; Prados-Torres A; Cura-González I;
    PLoS One; 2020; 15(8):e0237186. PubMed ID: 32785232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypharmacy: the challenge for nurses.
    Kaufman G
    Nurs Stand; 2016 May; 30(39):52-60. PubMed ID: 27224631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conceptualizing multiple drug use in patients with comorbidity and multimorbidity: proposal for standard definitions beyond the term polypharmacy.
    Kadam UT; Roberts I; White S; Bednall R; Khunti K; Nilsson PM; Lawson CA
    J Clin Epidemiol; 2019 Feb; 106():98-107. PubMed ID: 30385327
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.